U.S. Peripheral Nerve Stimulators Market (2025 - 2033) Size, Share & Trends Analysis Report By Product Type (Systems, Wearables/Accessories), By Modality (Rechargeable, Non-rechargeable), By Connectivity, By Application, By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product Type
                        1.2.2. Modality
                        1.2.3. Connectivity
                        1.2.4. Application
                        1.2.5. End Use
                    1.3. Estimates and Forecast Timeline
                    1.4. Research Methodology
                    1.5. Information Procurement
                        1.5.1. Purchased Database
                        1.5.2. GVR’s Internal Database
                        1.5.3. Secondary Sources
                        1.5.4. Primary Research
                        1.5.5. Information Analysis
                        1.5.6. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis
                    1.8. List of Secondary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Peripheral Nerve Stimulators Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Ancillary Market Outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                            3.2.1.1. High and rising prevalence of chronic pain
                            3.2.1.2. Shift away from opioids toward non-opioid/interventional therapies
                            3.2.1.3. Evidence and real-world adoption showing clinical benefit
                        3.2.2. Market Restraint Analysis
                            3.2.2.1. High device and procedure costs
                            3.2.2.2. Technological limitations
                        3.2.3. Market Opportunities Analysis
                            3.2.3.1. Outpatient centers and ambulatory surgery as key settings
                            3.2.3.2. Aging population and comorbidities
                        3.2.4. Market Challenges Analysis
                            3.2.4.1. Device-related risks and complications
                            3.2.4.2. Intense market competition
                            3.3. U.S. Peripheral Nerve Stimulators Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Bargaining power of suppliers
                            3.3.1.2. Bargaining power of buyers
                            3.3.1.3. Threat of substitutes
                            3.3.1.4. Threat of new entrants
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political & Legal Landscape
                            3.3.2.2. Economic and Social Landscape
                            3.3.2.3. Technological landscape
Chapter 4. U.S. Peripheral Nerve Stimulators Market: Product Type Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. U.S. Peripheral Nerve Stimulators Market Product Type Movement Analysis
                    4.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
                    4.4. Systems
                        4.4.1. Systems U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                            4.4.1.1. Implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                                4.4.1.1.1. Handheld
                                4.4.1.1.2. Others
                            4.4.1.2. Non-implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    4.5. Wearables/Accessories
                        4.5.1. Wearables/Accessories U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Peripheral Nerve Stimulators Market: Modality Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. U.S. Peripheral Nerve Stimulators Market Modality Movement Analysis
                    5.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
                    5.4. Rechargeable
                        5.4.1. Rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    5.5. Non-rechargeable
                        5.5.1. Non-rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Peripheral Nerve Stimulators Market: Connectivity Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
                    6.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
                    6.4. Wired
                        6.4.1. Wired U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    6.5. Wireless
                        6.5.1. Wireless U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Peripheral Nerve Stimulators Market: Application Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
                    7.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
                    7.4. Diabetic Peripheral Neuropathy Pain
                        7.4.1. Diabetic Peripheral Neuropathy Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.5. Chronic Musculoskeletal Pain
                        7.5.1. Chronic Musculoskeletal Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.6. Complex Regional Pain Syndrome (CRPS)
                        7.6.1. Complex Regional Pain Syndrome (CRPS) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.7. Headache and Migraine Disorders
                        7.7.1. Headache and Migraine Disorders U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    7.8. Others
                        7.8.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Peripheral Nerve Stimulators Market: End-Use Estimates & Trend Analysis
                    8.1. Segment Dashboard
                    8.2. U.S. Peripheral Nerve Stimulators Market End-Use Movement Analysis
                    8.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
                    8.4. Hospitals and Clinics
                        8.4.1. Hospitals and Clinics U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    8.5. Ambulatory Surgical Centers (ASCs)
                        8.5.1. Ambulatory Surgical Centers (ASCs) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    8.6. Physiotherapy/Rehabilitation Centers
                        8.6.1. Physiotherapy/Rehabilitation Centers U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
                    8.7. Others
                        8.7.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Market Participant Categorization
                    9.2. Key Company Profiles
                        9.2.1. B. Braun Medical Inc.
                            9.2.1.1. Company Overview
                            9.2.1.2. Financial Performance
                            9.2.1.3. Modality Benchmarking
                            9.2.1.4. Strategic Initiatives
                        9.2.2. Nalu Medical, Inc
                            9.2.2.1. Company Overview
                            9.2.2.2. Financial Performance
                            9.2.2.3. Modality Benchmarking
                            9.2.2.4. Strategic Initiatives
                        9.2.3. Curonix LLC.
                            9.2.3.1. Company Overview
                            9.2.3.2. Financial Performance
                            9.2.3.3. Modality Benchmarking
                            9.2.3.4. Strategic Initiatives
                        9.2.4. SPR
                            9.2.4.1. Company Overview
                            9.2.4.2. Financial Performance
                            9.2.4.3. Modality Benchmarking
                            9.2.4.4. Strategic Initiatives
                        9.2.5. Vygon
                            9.2.5.1. Company Overview
                            9.2.5.2. Financial Performance
                            9.2.5.3. Modality Benchmarking
                            9.2.5.4. Strategic Initiatives
                        9.2.6. AirLife
                            9.2.6.1. Company Overview
                            9.2.6.2. Financial Performance
                            9.2.6.3. Modality Benchmarking
                            9.2.6.4. Strategic Initiatives
                        9.2.7. Neuspera Medical
                            9.2.7.1. Company Overview
                            9.2.7.2. Financial Performance
                            9.2.7.3. Modality Benchmarking
                            9.2.7.4. Strategic Initiatives
                        9.2.8. Anesthesia Associates, Inc.
                            9.2.8.1. Company Overview
                            9.2.8.2. Financial Performance
                            9.2.8.3. Modality Benchmarking
                            9.2.8.4. Strategic Initiatives
                        9.2.9. AVNS
                            9.2.9.1. Company Overview
                            9.2.9.2. Financial Performance
                            9.2.9.3. Modality Benchmarking
                            9.2.9.4. Strategic Initiatives
                        9.2.10. Mercury Medical
                            9.2.10.1. Company Overview
                            9.2.10.2. Financial Performance
                            9.2.10.3. Modality Benchmarking
                            9.2.10.4. Strategic Initiatives
                        9.2.11. Medtronic
                            9.2.11.1. Company Overview
                            9.2.11.2. Financial Performance
                            9.2.11.3. Modality Benchmarking
                            9.2.11.4. Strategic Initiatives
                        9.2.12. Boston Scientific Corporation
                            9.2.12.1. Company Overview
                            9.2.12.2. Financial Performance
                            9.2.12.3. Modality Benchmarking
                            9.2.12.4. Strategic Initiatives
                        9.2.13. Abbott
                            9.2.13.1. Company Overview
                            9.2.13.2. Financial Performance
                            9.2.13.3. Modality Benchmarking
                            9.2.13.4. Strategic Initiatives
                        9.2.14. Bioventus
                            9.2.14.1. Company Overview
                            9.2.14.2. Financial Performance
                            9.2.14.3. Modality Benchmarking
                            9.2.14.4. Strategic Initiatives
                        9.2.15. Checkpoint Surgical Inc.
                            9.2.15.1. Company Overview
                            9.2.15.2. Financial Performance
                            9.2.15.3. Modality Benchmarking
                            9.2.15.4. Strategic Initiatives
                        9.2.16. Nervonik, Inc
                            9.2.16.1. Company Overview
                            9.2.16.2. Financial Performance
                            9.2.16.3. Modality Benchmarking
                            9.2.16.4. Strategic Initiatives
                    9.3. Company Market Share Analysis, 2024
                    9.4. List of Other Key Market Players

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Peripheral Nerve Stimulators Market, by Product Type, 2021 - 2033 (USD Million)
Table 4 U.S. Peripheral Nerve Stimulators Market, by Modality, 2021 - 2033 (USD Million)
Table 5 U.S. Peripheral Nerve Stimulators Market, by Connectivity, 2021 - 2033 (USD Million)
Table 6 U.S. Peripheral Nerve Stimulators Market, by Application, 2021 - 2033 (USD Million)
Table 7 U.S. Peripheral Nerve Stimulators Market, by End-Use, 2021 - 2033 (USD Million)
Table 8 Participant’s Overview
Table 9 Financial Performance
Table 10 Modality Benchmarking
Table 11 Strategic Initiatives

List of Figures

Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 U.S. Peripheral Nerve Stimulators Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Regional Marketplace: Key Takeaways
Fig. 13 U.S. Peripheral Nerve Stimulators Market, for Product Type, 2021 - 2033 (USD Million)
Fig. 14 U.S. Peripheral Nerve Stimulators Market, for Systems, 2021 - 2033 (USD Million)
Fig. 15 U.S. Peripheral Nerve Stimulators Market, for Implantable, 2021 - 2033 (USD Million)
Fig. 16 U.S. Peripheral Nerve Stimulators Market, for Non-Implantable, 2021 - 2033 (USD Million)
Fig. 17 U.S. Peripheral Nerve Stimulators Market, for Handheld, 2021 - 2033 (USD Million)
Fig. 18 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)
Fig. 19 U.S. Peripheral Nerve Stimulators Market, for Wearables/Accessories, 2021 - 2033 (USD Million)
Fig. 20 U.S. Peripheral Nerve Stimulators Market, for Rechargeable, 2021 - 2033 (USD Million)
Fig. 21 U.S. Peripheral Nerve Stimulators Market, for Non-rechargeable, 2021 - 2033 (USD Million)
Fig. 22 U.S. Peripheral Nerve Stimulators Market, for Connectivity, 2021 - 2033 (USD Million)
Fig. 23 U.S. Peripheral Nerve Stimulators Market, for Wired, 2021 - 2033 (USD Million)
Fig. 24 U.S. Peripheral Nerve Stimulators Market, for Wireless, 2021 - 2033 (USD Million)
Fig. 25 U.S. Peripheral Nerve Stimulators Market, for Application, 2021 - 2033 (USD Million)
Fig. 26 U.S. Peripheral Nerve Stimulators Market, for Diabetic Peripheral Neuropathy Pain, 2021 - 2033 (USD Million)
Fig. 27 U.S. Peripheral Nerve Stimulators Market, for Chronic Musculoskeletal Pain, 2021 - 2033 (USD Million)
Fig. 28 U.S. Peripheral Nerve Stimulators Market, for Complex Regional Pain Syndrome (CRPS), 2021 - 2033 (USD Million)
Fig. 29 U.S. Peripheral Nerve Stimulators Market, for Headache and Migraine Disorders, 2021 - 2033 (USD Million)
Fig. 30 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)
Fig. 31 U.S. Peripheral Nerve Stimulators Market, for End Use, 2021 - 2033 (USD Million)
Fig. 32 U.S. Peripheral Nerve Stimulators Market, for Hospitals and Clinics, 2021 - 2033 (USD Million)
Fig. 33 U.S. Peripheral Nerve Stimulators Market, for Ambulatory Surgical Centers (ASCs), 2021 - 2033 (USD Million)
Fig. 34 U.S. Peripheral Nerve Stimulators Market, for Physiotherapy/Rehabilitation Centers, 2021 - 2033 (USD Million)
Fig. 35 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)